| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:2472.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the Seaman Family MR Research Centre (S.B.C., A.M.B., A.M.D.), Foothills Medical Centre, Calgary Health Region; the Departments of Clinical Neurosciences (S.B.C., M.E., M.D.H., J.H.W.P., M.E.H., A.M.B., A.M.D.), Medicine and Community Health Sciences (M.E., M.D.H.), and Radiology (M.E.H.), University of Calgary, Alberta, Canada; and the Departments of Radiology (M.H.L., L.R., R.G.G.) and Neurology (L.H.S., W.J.K.), Massachusetts General Hospital, Harvard Medical School, Boston.
Correspondence to Dr Shelagh Coutts, Seaman Family MR Centre, Foothills Hospital, 1403 29th ST NW, Calgary, Alberta T2N 2T9. E-mail shelagh.coutts{at}calgaryhealthregion.ca
| Abstract |
|---|
|
|
|---|
Methods ASPECTS was assigned by 2 raters on the acute NCCT, CTA-SI, and follow-up imaging. The mean baseline ASPECTS of acute NCCT and CTA-SI was compared with the follow-up ASPECTS. Rate ratios (RRs) were used to quantify the relationship between the dichotomized baseline ASPECTS (categorized as 0 to 7 versus 8 to 10) and favorable patient outcome.
Results Thirty-nine patients were recruited. Proximal occlusion (internal carotid artery or middle cerebral artery) was seen in 62%, M2 occlusion in 18%, and no occlusion was seen in 20% of patients. The median time between symptom onset and imaging was 1.9 (1.2 to 2.5) hours. There was a significantly larger difference of 1.4 between the mean baseline NCCT and CTA-SI ASPECTS in patients who had more ischemic changes (follow-up ASPECTS=0 to 3) than a difference of 0.6 in patients who had near-to-normal CT scans (follow-up ASPECTS=8 to 10). The rate of favorable outcome for acute NCCT ASPECTS of 8 to 10 was 51.8% versus 25.0% for 0 to 7 (RR, 2.1, 95% CI: 0.7 to 5.9, P=0.12). For acute CTA-SI ASPECTS of 8 to 10, the rate of favorable outcome was 58.8% versus 31.8% for 0 to 7 (RR, 1.8, 95% CI: 0.9 to 3.8, P=0.09).
Conclusions CTA-SI ASPECTS provides added information in the prediction of final infarct size.
Key Words: computed tomography stroke, acute thrombolysis
| Introduction |
|---|
|
|
|---|
With the use of multislice CT scanners, the potential information available from a CT scan has increased.4 CT angiography and CT perfusion techniques can refine the current clinical criteria for patient selection for thrombolysis.5 Source images from CT angiography (CTA-SI) can be rapidly obtained with minimal delays after a NCCT in the emergency room.6,7,8 Although CTA has been shown to have value in identifying vessel occlusion, CTA-SI may also aid in the assessment of tissue status. Schramm et al found that the combination of CT, CTA, and CTA-SI was comparable to that of a magnetic resonance diffusion-weighted imaging.9 CTA-SI can also be useful in predicting final infarct volume.10,11 Brain tissue with a low cerebral blood volume appears as a region without enhancement on CTA-SI, effectively delineating the regions of ischemia.11 The Alberta Stroke Program Early CT Score (ASPECTS) was developed as a grading instrument to assess early ischemic changes on pretreatment CT scans in patients with acute ischemic stroke of the middle cerebral artery (MCA).12,13 The ASPECTS divides the MCA territory into 10 regions of interest. With training and experience, the early changes of acute ischemia can be reliably detected.13 One advantage of ASPECTS is that it combines a semiquantitative estimate of volume along with localization. It weights smaller volumes in the basal ganglia and internal capsule equally with larger volumes of brain designated M1 through M6.2 This approach is useful because lesion volume alone on NCCT is only weakly correlated with neurological outcome.14
In this study, we sought to assess whether the final infarct ASPECTS and clinical outcome were associated with the acute CTA-SI ASPECTS.
| Subjects and Methods |
|---|
|
|
|---|
Imaging
Standard NCCT was performed with a multislice CT scanner (GE Medical Systems) using 120 kV, 170 mA, 2-second scan time, and 5-mm slice thickness. Coverage was from skull base to vertex with contiguous axial slices parallel to the inferior orbitomeatal line.
NCCT scanning was followed immediately on the same scanner by CTA imaging with a helical scan technique. Previous work has shown that this adds
10 minutes to the scanning time.10 Acquisitions were obtained after a single bolus intravenous contrast injection of 90 to120 mL of nonionic contrast into an antecubital vein at 3 to 4 mL/s with a 20 to 25 s delay from the start of the contrast injection to the onset of imaging. The image sequence covered the foramen magnum to centrum semiovale or vertex with a scan field of view (25.0 cm; 140 kV, 170 mA; table speed 3.75 mm/s; 2.5-mm slice thickness with 2.5-mm interval; 1.0 s per rotation). Source images (CTA-SI) were reconstructed to 1.25-mm thickness at 0.625-mm intervals.
Follow-up imaging was performed on all patients. T2-weighted MRI was substituted among patients for whom follow-up NCCT was unavailable. All follow-up imaging was performed at a minimum of 24 hours after symptom onset. Clinical outcome was assessed using the modified Rankin Scale during an in-clinic visit. Favorable patient outcome at 90 days was defined as a Rankin score of 0 or 1.
Image Analysis
The assignment of an ASPECTS to each patients image was performed independently by a neuroradiologist and a stroke neurologist. Both readers were experienced in the interpretation of CT scans in acute stroke. Two other individuals, a neuroradiologist and a stroke neurologist, interpreted a subset of images for calculation of interrater agreement. Raters were blinded to all clinical information except for symptom side. The scoring of NCCT, CTA-SI, and follow-up imaging (NCCT or MRIfluid-attenuated inversion recovery [FLAIR]) was in a random order. Baseline and follow-up imaging interpretation was spaced over several weeks.
All images were reviewed digitally at a workstation with a large high-resolution monitor. Care was taken to use optimal width and level settings during CT image review to maximize the contrast produced by the small attenuation difference between normal and hypodense brain parenchyma.15 NCCT images were evaluated for evidence of focal parenchymal low attenuation, loss of gray-white differentiation, and sulcal effacement using ASPECTS as previously described.12 On the CTA-SI, regions of relatively diminished contrast enhancement were scored as abnormal (Figure 1). The CTA-SI was viewed at the window and level that allowed the maximum contrast between normal and ischemic tissue.15 The CTA-SI and circle of Willis maximum intensity projection reconstructions of the CT angiogram were evaluated for the presence of occlusion. ASPECTS on MRI was assigned in a similar manner to NCCT as previously described.16
|
Statistical Analyses
The unit of analysis was the mean of the 2 readers ASPECTS. Two-factor repeated measures ANOVA was used to compare the mean baseline ASPECTS of acute NCCT and CTA-SI. In the analysis of variance, the between-subject factor was the follow-up ASPECTS, categorized as 0 to 3, 4 to 7, and 8 to 10. The within-subject factor was the baseline ASPECTS, because the NCCT and CTA-SI scores were obtained from the same patients CT scan. Rate ratios (RRs) were used to quantify the relationship between the dichotomized baseline ASPECTS (categorized as 0 to 7 versus 8 to 10) and favorable patient outcome. The chosen cut point has been previously used for acute ischemic stroke patients.2,12,13 Interrater agreement in assigning ASPECTS was estimated using an intraclass correlation coefficient, computed from 1-way ANOVA.
| Results |
|---|
|
|
|---|
The overall mean baseline ASPECTS differed by 1.1 (P <0.001). Figure 2 summarizes the mean differences at each follow-up ASPECTS category. There was a significantly larger difference of 1.4 between the mean baseline NCCT and CTA-SI ASPECTS in patients who had more ischemic changes (follow-up ASPECTS=0 to 3) than a difference of 0.6 in patients who had near-to-normal CT scans (follow-up ASPECTS=8 to 10). There were no cases of CTA-SI overestimating the final infarct size. There were 10 cases in which the NCCT was rated as having an ASPECTS of 10 by at least 1 rater. In 3 cases, the NCCT, the CTA-SI, and the follow-up CT were rated by both observers as having an ASPECTS of 10. In 7 of the cases that ultimately had a stroke, (follow-up ASPECTS <10) 1 reader interpreted the NCCT as normal (ASPECTS 10), but interpreted the CTA-SI as showing at least some ischemic change (ASPECTS <10). There was no evidence of reversibility of CTA-SI seen in this study. Figure 3 shows a scatter plot of mean ASPECTS scores for CTA-SI and NCCT as compared with final ASPECTS scores on follow-up imaging.
|
|
The rate of favorable outcome for NCCT ASPECTS of 8 to 10 was 51.8% versus 25.0% for 0 to 7 (RR, 2.1; 95% CI, 0.7 to 5.9; P=0.12). For CTA-SI ASPECTS of 8 to 10, the rate of favorable outcome was 58.8% versus 31.8% for 0 to 7 (RR, 1.8; 95% CI, 0.9 to 3.8; P=0.09).
The interrater agreement for baseline ASPECTS using NCCT was 0.71 versus 0.73 for CTA-SI.
| Discussion |
|---|
|
|
|---|
1/3 of infarcts that later appeared on follow-up CT,17 and the National Institute of Neurological Disorders and Stroke (NINDS) investigators reported that only 31% of patients in the NINDS tPA trial had evidence of early ischemic changes.18 Our results suggest that CTA-SI ASPECTS has a greater sensitivity to ischemic changes and more accurately identifies the volume of tissue that will ultimately infarct compared with NCCT alone. The cases where 1 rater scored the scan as 10 show the potential advantage of using CTA-SI. In 7 of these cases, the ischemia would have been totally missed by 1 of the expert raters. It is in this setting (ASPECTS=10 of the NCCT) where CTA-SI is most likely to be helpful. CTA is 1 method of quickly and accurately identifying vessel occlusion and ischemia. Using a follow-up ASPECTS as the final infarct size, CTA-SI gives a more accurate estimate of tissue that is at risk of infarcting than does a NCCT alone. The value of a combined CTA, CTA-SI over NCCT in predicting clinical outcome has also been demonstrated using a scale that differs from ASPECTS.19
It is important to recognize that hypoattentuation on NCCT and CTA-SI hypoattenuation probably imply different pathophysiological abnormalities. These may not always represent core of infarction. A CTA-SI region showing a lack of enhancement provides an estimate of cerebral blood volume,10,11 whereas NCCT measures shifts in brain tissue water content. It is the net uptake of water in brain regions with <12 mL/100 gxminutes20,21 that causes hypoattenuation. Large shifts of water are needed for the human eye to visualize hypoattenuation. Animal studies have shown that a 1% increase in brain water content results in an x-ray attenuation decrease of 2 to 3 Hounsfield units.22 Optimal window width and leveling15 can help with reliably identifying such changes in water content. Recent work confirms that the volume of abnormality on CTA-SI at baseline is a very close match to the volume of final infarct on follow-up scanning if there is prompt recanalization.15 Further work is needed on this subject.
Both NCCT and CTA-SI showed a trend toward a better clinical outcome for baseline ASPECTS of 8 to 10. This is consistent with observations from the Prolyse in Acute Cerebral Thromboembolism Trial (PROACT II) where an ASPECTS of 8 to 10 was found to differentially predict response to thrombolytic treatment.2 Larger numbers of patients will be needed to assess and confirm the relationship of ASPECTS on CTA-SI with clinical outcome.
The possibility of CT fogging effect is a relative limitation of our study. The timing and degree of fogging is variable, and has mostly been studied in small series, on older generation CT scanners.23,24 More recent studies suggest that fogging can start as early as 5 to 10 days post ictus, but that it may also occur months after stroke onset, coincident with the time period of poststroke hyperemia25 (a potential mechanism of fogging). The timing and degree of fogging likely varies with factors such as infarct size as well as the severity of the initial deficit.26 Importantly for our results, previous work suggests that fogging of large infarcts is typically not complete.
The reliability of assessing ASPECTS on the CTA-SI was very good and similar to that on NCCT. Larger studies are needed very early from stroke onset to compare both techniques. NCCT changes are particularly difficult to appreciate in such patients and may be greatly aided by CTA-SI information.
| Acknowledgments |
|---|
Received February 11, 2004; revision received July 29, 2004; accepted July 30, 2004.
| References |
|---|
|
|
|---|
2. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Weschler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CA, Schulz G, Buchan AM, Selection of acute ischemic stroke patients for intra-arterial thrombolysis with prourokinase using ASPECTS. Stroke. 2003; 34: 19251931.
3. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997; 205: 327333.
4. Koroshetz WJ, Gonzales RG. Imaging stroke in progress: magnetic resonance advances but computed tomography is poised for counterattack. Ann Neurol. 1999; 46: 556558.[CrossRef][Medline] [Order article via Infotrieve]
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333: 15811587.
6. Hunter GJ, Hamberg LM, Ponzo JA, Huang-Hellinger FR, Morris PP, Rabinov J, Farkas J, Lev MH, Schaefer PW, Ogilvy CS, Schwamm L, Buonanno FS, Koroshetz WJ, Wolf GL, Gonzalez RG. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol. 1998; 19: 2937.[Abstract]
7. Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W. Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke. 1998; 29: 935938.
8. Smith WS, Roberts HC, Chuang NA, Ong KC, Lee TJ, Johnston SC, Dillon WP. Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol. 2003; 24: 688690.
9. Schramm P, Schellinger PD, Fiebach JB, Heiland S, Jansen O, Knauth M, Hacke W, Sartor K. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke. 2002; 33: 24262432.
10. Lev MH, Segal AZ, Farkas J, Hossain ST, Putman C, Hunter GJ, Budzik R, Harris GJ, Buonanno FS, Ezzeddine MA, Chang Y, Koroshetz WJ, Gonzalez RG, Schwamm LH. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke. 2001; 32: 20212028.
11. Ezzeddine MA, Lev MH, McDonald CT, Rordorf G, Oliveira-Filho J, Aksoy FG, Farkas J, Segal AZ, Schwamm LH, Gonzalez RG, Koroshetz WJ. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke. 2002; 33: 959966.
12. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001; 22: 15341542.
13. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000; 355: 16701674.[CrossRef][Medline] [Order article via Infotrieve]
14. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke. 2000; 31: 29122919.
15. Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, Gonzalez RG. Acute stroke: improved nonenhanced CT detectionbenefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999; 213: 150155.
16. Barber PA, Demchuk AM, Hill MD, Pexman W, Hudon ME, Tomanek A, Beaupre D, Frayne R, Buchan AM. A comparison of CT versus MR imaging in acute stroke using ASPECTS: will the "new" replace the "old" as the preferred Imaging modality? Stroke. 2001; 32: 325. Abstract.
17. von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, Hacke W. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology. 2001; 219: 95100.
18. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC Jr., Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KM; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001; 286: 28302838.
19. Nabavi DG, Kloska SP, Nam EM, Freund M, Gaus CG, Klotz E, Heindel W, Ringelstein EB. MOSAIC: Multimodal Stroke Assessment Using Computed Tomography: novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke. 2002; 33: 28192826.
20. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke. 1980; 11: 593601.
21. Dzialowski I, Weber J, Doerfler A, Forsting M, von Kummer R. Brain tissue water uptake after middle cerebral artery occlusion assessed with CT. J Neuroimaging,. 2004; 14: 4248.[CrossRef][Medline] [Order article via Infotrieve]
22. Unger E, Littlefield J, Gado M. Water content and water structure in CT and MR signal changes: possible influence in detection of early stroke. AJNR. 1988; 9: 687691.[Abstract]
23. Skriver EB, Olsen TS. Transient disappearance of cerebral infarcts on CT scan, the so-called fogging effect. Neuroradiology. 1981; 22: 6165.[CrossRef][Medline] [Order article via Infotrieve]
24. Becker H, Desch H, Hacker H, Pencz A. CT fogging effect with ischemic cerebral infarcts. Neuroradiology. 1979; 18: 185192.[CrossRef][Medline] [Order article via Infotrieve]
25. De Reuck J, Van de Velde E, Van Maele G, Wissaert W. The prognostic significance of changes in X-ray attenuation on CT in established cerebral infarcts. Cerebrovasc Dis. 2003; 16: 114121.[CrossRef][Medline] [Order article via Infotrieve]
26. Launay M, N[prime]Diaye M, Bories J. X-ray computed tomography (CT) study of small, deep and recent infarcts (SDRIs) of the cerebral hemispheres in adults. Preliminary and critical report. Neuroradiology. 1985; 27: 494508.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E.S. Rosenthal, L.H. Schwamm, L. Roccatagliata, S.B. Coutts, A.M. Demchuk, P.W. Schaefer, R.G. Gonzalez, M.D. Hill, E.F. Halpern, and M.H. Lev Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1471 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Puetz, P.N. Sylaja, S. B. Coutts, M. D. Hill, I. Dzialowski, P. Mueller, U. Becker, G. Urban, C. O'Reilly, P. A. Barber, et al. Extent of Hypoattenuation on CT Angiography Source Images Predicts Functional Outcome in Patients With Basilar Artery Occlusion Stroke, September 1, 2008; 39(9): 2485 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Torres-Mozqueda, J. He, I.B. Yeh, L.H. Schwamm, M.H. Lev, P.W. Schaefer, and R.G. Gonzalez An Acute Ischemic Stroke Classification Instrument That Includes CT or MR Angiography: The Boston Acute Stroke Imaging Scale AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1111 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lin, O. Rapalino, M. Law, J.S. Babb, K.A. Siller, and B.K. Pramanik Accuracy of the Alberta Stroke Program Early CT Score during the First 3 Hours of Middle Cerebral Artery Stroke: Comparison of Noncontrast CT, CT Angiography Source Images, and CT Perfusion AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 931 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Butcher, M. Parsons, L. Allport, S. B. Lee, P. A. Barber, B. Tress, G. A. Donnan, S. M. Davis, and for the EPITHET Investigators Rapid Assessment of Perfusion-Diffusion Mismatch Stroke, January 1, 2008; 39(1): 75 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.I. Aviv, J. Mandelcorn, S. Chakraborty, D. Gladstone, S. Malham, G. Tomlinson, A.J. Fox, and S. Symons Alberta Stroke Program Early CT Scoring of CT Perfusion in Early Stroke Visualization and Assessment AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1975 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. S. Camargo, K. L. Furie, A. B. Singhal, L. Roccatagliata, M. E. Cunnane, E. F. Halpern, G. J. Harris, W. S. Smith, R. G. Gonzalez, W. J. Koroshetz, et al. Acute Brain Infarct: Detection and Delineation with CT Angiographic Source Images versus Nonenhanced CT Scans Radiology, August 1, 2007; 244(2): 541 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. DeLaPaz and for the Expert Panel on Neurologic Imaging Cerebrovascular Disease AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1197 - 1199. [Full Text] [PDF] |
||||
![]() |
S. C. Jones, A. Kharlamov, B. Yanovski, D. K. Kim, K. A. Easley, V. E. Yushmanov, S. K. Ziolko, and F. E. Boada Stroke Onset Time Using Sodium MRI in Rat Focal Cerebral Ischemia Stroke, March 1, 2006; 37(3): 883 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.N. Sylaja, I. Dzialowski, A. Krol, J. Roy, P. Federico, A. M. Demchuk, and Calgary Stroke Program Role of CT Angiography in Thrombolysis Decision-Making for Patients With Presumed Seizure at Stroke Onset Stroke, March 1, 2006; 37(3): 915 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Demchuk, M. D. Hill, P. A. Barber, B. Silver, S. C. Patel, S. R. Levine, and for the NINDS rtPA Stroke Study Group, NIH Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study Stroke, October 1, 2005; 36(10): 2110 - 2115. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |